Related Experiment Video
Updated: Jun 6, 2025

08:14
A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
Published on: February 28, 2018
8.8K
Bile's Hidden Weapon: Modulating the Microbiome and Tumor Microenvironment
Mohamed J Saadh1, Hanan Hassan Ahmed2, Ali Fawzi Al-Hussainy3
1Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.
Current Microbiology
|November 30, 2024
Summary
Bile influences the gut microbiome, altering the tumor microenvironment (TME) to promote cancer growth and therapy resistance. Targeting the gut-bile-TME axis offers new therapeutic strategies for improved patient outcomes.
Area of Science:
- Microbiology
- Oncology
- Gastroenterology
Background:
- The human gut microbiome is essential for health but is influenced by bile acids.
- Bile acids, produced by the liver, modulate gut microbial composition and function.
- Alterations in the gut microbiome can impact the tumor microenvironment (TME).
Purpose of the Study:
- To review the complex interplay between bile, the gut microbiome, and the TME.
- To elucidate mechanisms driving cancer progression and therapy resistance via this axis.
- To highlight the potential for novel therapeutic strategies targeting the gut-bile-TME axis.
Main Methods:
- Literature review of existing research on bile, gut microbiome, and cancer.
- Analysis of mechanisms linking bile acid metabolism, microbiome alterations, and TME modulation.
- Synthesis of findings to understand cancer progression and therapeutic resistance.
Main Results:
- Bile acids shape the gut microbiome, influencing its function and promoting an immunosuppressive TME.
- Altered gut microbiome profiles driven by bile can enhance tumor growth and metastasis.
- The gut-bile-TME axis contributes to cancer cell behavior and resistance to therapies.
- Bile acids can increase antibiotic resistance within the gut microbiome.
Conclusions:
- The intricate relationship between bile, the gut microbiome, and the TME is a key driver of cancer progression and therapeutic resistance.
- Targeting the gut-bile-TME axis presents a promising avenue for developing novel cancer therapies.
- Further understanding of these interactions is critical for improving patient outcomes in oncology.

